Loss of Consciousness After Naltrexone Implantation: A Case Report.

Oğuzhan Doğan
{"title":"Loss of Consciousness After Naltrexone Implantation: A Case Report.","authors":"Oğuzhan Doğan","doi":"10.5080/u26711","DOIUrl":null,"url":null,"abstract":"<p><p>Naltrexone is an μ opioid receptor antagonist that is used in alcohol and opiate use disorder. Naltrexone does not constitute tolerance and dependence, and cessation of the drug does not cause withdrawal symptoms. Sustained release form of naltrexone has been developed due to patient compliance issues. There is currently only one sustainedrelease form available in Turkey, which is inserted subcutaneously. In this case report, we present, a probable serious side effect of sustained release naltrexone implant. A 36 years old male with alcohol use disorder, developed a sudden clouding of consciousness one hour after the naltrexone implant application followed by anterograde amnesia in the next 8-10 hours. We were not able to detect any medical or neurological reasons for the altered mental status but after the removal of the naltrexone implant, the symptoms improved. To the best of our knowledge, this is the first case to report clouding of consciousness and anterograde amnesia after naltrexone implantation. Keywords: Naltrexone Implant, Side Effect, Alcohol Use Disorder, Lethargy, Consciousness.</p>","PeriodicalId":94262,"journal":{"name":"Turk psikiyatri dergisi = Turkish journal of psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11375739/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turk psikiyatri dergisi = Turkish journal of psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5080/u26711","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Naltrexone is an μ opioid receptor antagonist that is used in alcohol and opiate use disorder. Naltrexone does not constitute tolerance and dependence, and cessation of the drug does not cause withdrawal symptoms. Sustained release form of naltrexone has been developed due to patient compliance issues. There is currently only one sustainedrelease form available in Turkey, which is inserted subcutaneously. In this case report, we present, a probable serious side effect of sustained release naltrexone implant. A 36 years old male with alcohol use disorder, developed a sudden clouding of consciousness one hour after the naltrexone implant application followed by anterograde amnesia in the next 8-10 hours. We were not able to detect any medical or neurological reasons for the altered mental status but after the removal of the naltrexone implant, the symptoms improved. To the best of our knowledge, this is the first case to report clouding of consciousness and anterograde amnesia after naltrexone implantation. Keywords: Naltrexone Implant, Side Effect, Alcohol Use Disorder, Lethargy, Consciousness.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
植入纳曲酮后意识丧失:病例报告。
纳曲酮是一种μ阿片受体拮抗剂,用于治疗酒精和阿片类药物使用障碍。纳曲酮不会产生耐受性和依赖性,停药也不会引起戒断症状。由于患者的依从性问题,已开发出纳曲酮的缓释剂型。目前土耳其只有一种皮下注射的缓释剂型。在本病例报告中,我们介绍了纳曲酮缓释植入剂可能产生的严重副作用。一名酗酒的 36 岁男性在植入纳曲酮 1 小时后突然意识模糊,随后 8-10 小时内出现逆行性遗忘。我们未能发现导致精神状态改变的任何医学或神经学原因,但在移除纳曲酮植入物后,症状有所改善。据我们所知,这是首例报告植入纳曲酮后出现意识模糊和逆行性遗忘的病例。关键词纳曲酮植入 副作用 酒精使用障碍 嗜睡 意识模糊
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A psychopathological reading of the blood sweat phenomenon and religious stigmas: The case of Blessed Elena Aiello. Association between Symptom Dimensions and Psychosis Risk Factors with Functioning in First Episode Psychosis: A Six Months Prospective Study. Can there be a genetic marker for Post-Traumatic Stress Disorder outside the Diagnostic Interview within the Scope of Forensic Psychiatry? COVID-19 AND MANIA: A CASE WITH A ONE-YEAR FOLLOW UP. Hepatitis C Prevalence, HCV awareness and Certain Psychological Factors in Patients with Opioid Use Disorder.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1